In patients with cytogenetically normal acute myeloid leukemia, in whom FLT3‐ITD is a common mutation, overexpression of genes from the BER, NER, Fanconi anemia (FA), MMR, and HR pathways was associated with poor clinical prognosis. Here, FLT3 is linked to acute myeloid leukemia.